News

Update on Potential Treatments for Imatinib-Resistant GIST

In a recent article entitled "Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions" published online in Springer for Research and Development,  LRG Research Team member Sebastian Bauer [...]

By |2019-10-31T12:01:30-04:00July 31st, 2015|News, Research|

ASCO Recommends Expanding Clinical Trials to Include More Older Adults

A recent call to action from ASCO (American Society of Clinical Oncology) published in the Journal of Clinical Oncology recommends expanding clinical trials to include more older adults. Given that greater than 60% of cancers in [...]

By |2018-11-05T15:21:56-05:00July 23rd, 2015|Advocacy, Clinical Trials, News|

New Study Reviews Follow-Up Treatment Strategies for GIST

In a recent article in the May 2015 edition of the European Journal of Cancer, Heikki Joensuu, one of the foremost authorities on adjuvant treatment for GIST, discussed how follow-up treatment is currently performed for [...]

By |2018-11-05T15:34:20-05:00June 30th, 2015|News, Research, Survival Strategies|

Regorafenib-Related Hand-Foot Skin Reaction

A recent comprehensive review of the literature of the PubMed database and of the clinical experiences of oncologists and dermatologists concerning patients with regorafenib (Stivarga) related hand-foot skin reaction (HFSR) was published in the [...]

By |2019-10-31T13:40:24-04:00June 26th, 2015|Coping with GIST, News, Side Effects|

Being Your Own Warrior: Karen Darnell’s Personal Battle

Karen Darnell appreciates the value of life jackets. In her GIST journey, she recognizes the importance of having one constructed from the fabric of family support, GIST experts, email communities and the Life Raft [...]

By |2018-11-06T12:58:26-05:00June 16th, 2015|Member Stories, News|
Go to Top